| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/04/2007 | CN1993131A Film-coated tablet |
| 07/04/2007 | CN1993126A Use of a steroid for enhancement of skin permeability |
| 07/04/2007 | CN1993119A Composition containing statins and omega-3 fatty acids |
| 07/04/2007 | CN1993115A Compound formulations of 2-amino-1, 3-propanediol compounds |
| 07/04/2007 | CN1993110A Stable particle formulations of erythropoietin receptor agonists |
| 07/04/2007 | CN1990523A Preparing method of shell crosslinked polymers micelle, drug and gene vector thereof |
| 07/04/2007 | CN1990047A Elemene inclusion complex, preparation and preparation process thereof |
| 07/04/2007 | CN1990046A Macromolecule micelle with positive charge and forming method thereof |
| 07/04/2007 | CN1989967A Freeze drying injection of fasudil hydrochlorate and hydrate thereof |
| 07/04/2007 | CN1989964A Oral medication composition comprising loperamide |
| 07/04/2007 | CN1989963A Pharmaceutical compositions |
| 07/04/2007 | CN1324143C Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 07/04/2007 | CN1324112C Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 07/04/2007 | CN1324107C Spraying composition |
| 07/04/2007 | CN1323722C Positional isomers of PEG IFN alpha 2a |
| 07/04/2007 | CN1323721C Capsule covering containing ass-hide gelatin component and its prepn process and application |
| 07/04/2007 | CN1323720C Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 07/04/2007 | CN1323666C Stabilized aqueuos folic acid preparation and its production |
| 07/04/2007 | CN1323664C Sustained release ranolazine formulations |
| 07/04/2007 | CN1323663C Sustained-release tablet comprising reboxetine |
| 07/04/2007 | CN1323660C Medicament for the treatment of viral skin and tumour diseases |
| 07/04/2007 | CN1323658C Novel dry powder inhalation system for transpulmonary administration |
| 07/04/2007 | CN1323654C Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 07/03/2007 | US7238761 Gel of an acrylamide-methacrylamide copolymer crosslinked with 2-hydroxyethyl methacrylate and N,N'-methylene-bis-acrylamide, and water; use as carrier for culturing heterogeneous (allogenic or xenogenic) or autoimmune cells |
| 07/03/2007 | US7238705 Aporphine esters and their use in therapy |
| 07/03/2007 | US7238680 Topical compositions for veterinary uses |
| 07/03/2007 | US7238673 Genetic enginnering; kits |
| 07/03/2007 | US7238657 Cartilage/Bone inducing materials for preparation |
| 07/03/2007 | US7238369 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome |
| 07/03/2007 | US7238368 Releasable linkage and compositions containing same |
| 07/03/2007 | US7238367 Liposome loading with metal ions |
| 07/03/2007 | US7238364 Barrier or drug delivery system; conformation to three-dimensional structure; biodegradable, biocompatible |
| 07/03/2007 | US7238361 Smart drug delivery system |
| 07/03/2007 | US7238360 Getting the same result as gene therapy, without the introduction of exogenous DNA, by binding T cell with immunomodulator biotin, then contacting with avidin or streptavidin; apoptosis induction or resistance |
| 07/03/2007 | US7238349 Composition |
| 07/03/2007 | US7238347 Use of a mutant Leishmania responsive to external signals such as red or white light to become porphyric and commit suicidal cytolysis, immunizing a mammal |
| 07/03/2007 | US7238341 Peptide-based multimeric targeted contrast agents |
| 07/03/2007 | CA2447510C Fluorocarbon aerosol medicaments |
| 07/03/2007 | CA2433177C Hypoallergenic and non-irritant skin care formulations |
| 07/03/2007 | CA2416900C The use of a combination of a lipase inhibitor and a pharmaceutically acceptable bile acid sequestrant for the prevention and treatment of diseases associated with high plasma cholesterol levels |
| 07/03/2007 | CA2393585C Therapeutic agents |
| 07/03/2007 | CA2384859C High lipid diet |
| 07/03/2007 | CA2367131C Methods for fine powder formation |
| 07/03/2007 | CA2350884C Topical compositions comprising ascomycins |
| 07/03/2007 | CA2296425C Bright white film coatings and film coating compositions therefor |
| 07/03/2007 | CA2277429C A lactoferrin tablet |
| 07/03/2007 | CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/03/2007 | CA2256413C Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 07/03/2007 | CA2212168C Antimicrobial composition composed of controlled release glasses |
| 07/03/2007 | CA2174122C Therapeutic delivery compositions and methods of use thereof |
| 07/03/2007 | CA2108192C Use of tyloxapol as a nanoparticle stabilizer and dispersant |
| 06/29/2007 | CA2572112A1 System and kit treating tissue with radio frequency vascular electrode array |
| 06/29/2007 | CA2572106A1 Low temperature drying methods for forming drug-containing polymeric compositions |
| 06/29/2007 | CA2572100A1 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 06/29/2007 | CA2572057A1 A photoactive biocompatible coating composition |
| 06/28/2007 | WO2007073346A1 Water-soluble films comprising low-viscosity alginates |
| 06/28/2007 | WO2007073180A1 Controlled release gels |
| 06/28/2007 | WO2007072982A1 Protein nanoparticles and the use of the same |
| 06/28/2007 | WO2007072923A1 Preparation for external use having improved temporal stability of steroid |
| 06/28/2007 | WO2007072911A1 Preparation with improved bioabsorbability of sapropterin hydrochloride |
| 06/28/2007 | WO2007072908A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 06/28/2007 | WO2007072840A1 Orally disintegrating tablet comprising fat-soluble substance |
| 06/28/2007 | WO2007072756A1 Mineral absorption enhancer, food and feeding stuff |
| 06/28/2007 | WO2007072022A2 Composition comprising an antigen-recognizing molecule and a lipid-based carrier |
| 06/28/2007 | WO2007071915A2 Pharmaceutical product comprising porous silicon |
| 06/28/2007 | WO2007071815A1 Method for monitoring and promoting the nutrition and well-being of an animal and/or a human being as well as the productivity of animals |
| 06/28/2007 | WO2007071777A2 Immuno-rna-constructs |
| 06/28/2007 | WO2007071733A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 06/28/2007 | WO2007071068A1 Process for the production of preformed conjugates of albumin and a therapeutic agent |
| 06/28/2007 | WO2007071012A1 Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor |
| 06/28/2007 | WO2007071008A1 Compositions formulated for solvent-regulated drug release |
| 06/28/2007 | WO2007051923A3 Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof in particular for therapeutic purposes |
| 06/28/2007 | WO2007013480A3 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 06/28/2007 | WO2007012013A3 Polymer conjugates to therapeutic agents via an si-n and/or an si-o linkage |
| 06/28/2007 | WO2006122309A3 Stable lyophilized anthracycline glycosides |
| 06/28/2007 | WO2006041429A3 Tissue engineered meat for consumption and a method for producing tissue engineered meat for consumption |
| 06/28/2007 | WO2005113601A8 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 06/28/2007 | WO2005053637A3 Pharmaceutical spray formulation comprising a hypro fluor alkane amd an acylated cyclodextrin |
| 06/28/2007 | WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149441 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| 06/28/2007 | US20070148765 Preservative-containing virus formulations |
| 06/28/2007 | US20070148629 Composition for the preservation of viruses |
| 06/28/2007 | US20070148437 Thermosensitive, biocompatible polymer carriers with changeable physical structure for therapy, diagnostics and analytics |
| 06/28/2007 | US20070148264 Agent for the prevention and/or treatment of septicemia |
| 06/28/2007 | US20070148263 comprises curcumin and an essential oil of turmeric |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148254 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 06/28/2007 | US20070148246 Nucleic Acid-Based Matrixes |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148235 Pharmaceutical composition |
| 06/28/2007 | US20070148230 Medicament-containing particle and a solid preparation containing the particle |
| 06/28/2007 | US20070148228 Bioavailability; absorption; using a fatty acid, or salt thereof, or fatty ester ; sustained release; histone deacetylase inhibitor |
| 06/28/2007 | US20070148217 Percutaneous absorption type cerebral protective agent |
| 06/28/2007 | US20070148209 Allergic constitution ameliorator |
| 06/28/2007 | US20070148207 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/28/2007 | US20070148199 Preparations for topical skin use and treatment |
| 06/28/2007 | US20070148195 Compositions and methods for transdermal oxybutynin therapy |
| 06/28/2007 | US20070148192 Stable ophthalmic composition |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |